Targeting of intragraft reactive oxygen species by APP‐103, a novel polymer product, mitigates ischemia/reperfusion injury and promotes the survival of renal transplants-Reference-Cited by-同舟云学术

Targeting of intragraft reactive oxygen species by APP‐103, a novel polymer product, mitigates ischemia/reperfusion injury and promotes the survival of renal transplants

Published:2020-02-22 Issue:6 Volume:20 Page:1527-1537
ISSN:1600-6135
Container-title:American Journal of Transplantation
language:en
Short-container-title:Am J Transplant

Author:

Minami Koichiro¹²³,Bae Soochan⁴,Uehara Hirofumi¹²³,Zhao Chen⁵,Lee Dongwon⁶,Iske Jasper¹²⁷,Fanger Michael W.⁸,Reder Jake⁸,Morrison Ian⁹,Azuma Haruhito³,Wiens Astrid¹⁰,Van Keuren Edward⁵,Houser Brandy⁸^ORCID,ElKhal Abdala¹²,Kang Peter M.⁴,Tullius Stefan G.¹²

Affiliation:

1. Division of Transplant Surgery Brigham and Women’s Hospital Boston MassachusettsUSA

2. Harvard Medical School Boston MassachusettsUSA

3. Department of Urology Osaka Medical College Takatsuki‐city, Osaka Japan

4. Beth Israel Deaconess Medical Center Cardiovascular Institute Boston MassachusettsUSA

5. Department of Physics Institute for Soft Matter Synthesis and MetrologyGeorgetown University Washington DCUSA

6. Department of BIN Fusion Technology Chonbuk National University Jeonju South Korea

7. Integrated Research and Treatment Center Transplantation (IFB‐Tx) Institute of Transplant ImmunologyHannover Medical School Hannover Lower Saxony Germany

8. Celdara Medical LLC Lebanon New HampshireUSA

9. Owen Corporation LLC Georgetown Washington DCUSA

10. Department of Pathology Brigham and Women’s HospitalHarvard Medical School Boston MassachusettsUSA

Funder

National Institute of Diabetes and Digestive and Kidney Diseases

Deutscher Akademischer Austauschdienst

Publisher

Wiley

Subject

Pharmacology (medical),Transplantation,Immunology and Allergy

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/ajt.15794